Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Seidman

Showing results (461-470 of 533) with videos related to

Pageof 54
Sort By:
Human Molecular Genetics|August 27, 2013
Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in miceAndrea A Domenighetti, Pao-Hsien Chu, Tongbin Wu, et al.
Trials|March 21, 2014
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicineJason L Vassy, Denise M Lautenbach, Heather M McLaughlin, et al.
European Heart Journal|May 21, 2025
Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse modelTomas Baka, Jarrod Moore, Fuzhong Qin, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2012
Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart developmentKasper Lage, Steven C Greenway, Jill A Rosenfeld, et al.
The Journal of Clinical Investigation|June 3, 2024
Increased endothelial sclerostin caused by elevated DSCAM mediates multiple trisomy 21 phenotypesDavid M McKean, Qi Zhang, Priyanka Narayan, et al.
Circulation. Genomic and Precision Medicine|February 16, 2026
<i>ROBO2</i> Variants Associated With Atrial Septal Defect Define a Novel Regulatory ElementSeong Won Kim, Michael Parfenov, Laura Rodriguez-Murillo, et al.
The Journal of Clinical Investigation|January 2, 2025
Cardiac fibroblast BAG3 regulates TGFBR2 signaling and fibrosis in dilated cardiomyopathyBryan Z Wang, Margaretha Aj Morsink, Seong Won Kim, et al.
Circulation. Genomic and Precision Medicine|September 6, 2023
DMD-Associated Dilated Cardiomyopathy: Genotypes, Phenotypes, and PhenocopiesRenee Johnson, Robyn Otway, Ephrem Chin, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2022
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse modelAnna Axelsson Raja, Hiroko Wakimoto, Daniel M DeLaughter, et al.
Genome Medicine|May 1, 2020
EM-mosaic detects mosaic point mutations that contribute to congenital heart diseaseAlexander Hsieh, Sarah U Morton, Jon A L Willcox, et al.
Pageof 54

Showing results (461-470 of 533) with videos related to

Sort By:
Pageof 54
Human Molecular Genetics|August 27, 2013
Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in miceAndrea A Domenighetti, Pao-Hsien Chu, Tongbin Wu, et al.
Trials|March 21, 2014
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicineJason L Vassy, Denise M Lautenbach, Heather M McLaughlin, et al.
European Heart Journal|May 21, 2025
Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse modelTomas Baka, Jarrod Moore, Fuzhong Qin, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2012
Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart developmentKasper Lage, Steven C Greenway, Jill A Rosenfeld, et al.
The Journal of Clinical Investigation|June 3, 2024
Increased endothelial sclerostin caused by elevated DSCAM mediates multiple trisomy 21 phenotypesDavid M McKean, Qi Zhang, Priyanka Narayan, et al.
Circulation. Genomic and Precision Medicine|February 16, 2026
<i>ROBO2</i> Variants Associated With Atrial Septal Defect Define a Novel Regulatory ElementSeong Won Kim, Michael Parfenov, Laura Rodriguez-Murillo, et al.
The Journal of Clinical Investigation|January 2, 2025
Cardiac fibroblast BAG3 regulates TGFBR2 signaling and fibrosis in dilated cardiomyopathyBryan Z Wang, Margaretha Aj Morsink, Seong Won Kim, et al.
Circulation. Genomic and Precision Medicine|September 6, 2023
DMD-Associated Dilated Cardiomyopathy: Genotypes, Phenotypes, and PhenocopiesRenee Johnson, Robyn Otway, Ephrem Chin, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2022
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse modelAnna Axelsson Raja, Hiroko Wakimoto, Daniel M DeLaughter, et al.
Genome Medicine|May 1, 2020
EM-mosaic detects mosaic point mutations that contribute to congenital heart diseaseAlexander Hsieh, Sarah U Morton, Jon A L Willcox, et al.
Pageof 54